Description
IUPAC Name: [(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4-acetyloxy-1,9,12-trihydroxy-15-[(2R,3S)-2-hydroxy-3-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropanoyl]oxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate
InChI: InChI=1S/C43H53NO14/c1-22-26(55-37(51)32(48)30(24-15-11-9-12-16-24)44-38(52)58-39(3,4)5)20-43(53)35(56-36(50)25-17-13-10-14-18-25)33-41(8,34(49)31(47)29(22)40(43,6)7)27(46)19-28-42(33,21-54-28)57-23(2)45/h9-18,26-28,30-33,35,46-48,53H,19-21H2,1-8H3,(H,44,52)/t26-,27-,28+,30-,31+,32+,33-,35-,41+,42-,43+/m0/s1
InChIKey: ZDZOTLJHXYCWBA-VCVYQWHSSA-N
Canonical SMILES: CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O
Isomeric SMILES: CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O
Synonyms: docetaxel; 114977-28-5; Taxotere; Docetaxel anhydrous; Docetaxel Winthrop; Docetaxol; Docetaxel Kabi; EmDOC; …
Botanical Source: Taxus chinensis
Docetaxel is a semisynthetic taxane derived from the European yew tree (Taxus baccata). As a leading supplier of pharmaceutical-grade natural compounds, BIORLAB offers ultra-pure docetaxel for cancer research and drug development applications.
Technical Specifications
– Chemical Formula: 114977-28-5
– Molecular Weight: 807.9 g/mol
– Purity: ≥98% (HPLC)
– Appearance: White to off-white crystalline powder
– Solubility: Soluble in DMSO, ethanol, and methanol
Key Applications in Pharmaceutical Research
– Antineoplastic agent development
– Cancer cell biology studies
– Drug delivery system optimization
– Combination therapy research
– Bioavailability enhancement studies
Mechanism of Action
Docetaxel functions as a mitotic inhibitor by binding to and stabilizing microtubules, preventing cell division, and triggering apoptosis in rapidly dividing cancer cells. This mechanism makes it particularly valuable for:
– Breast cancer research
– Non-small cell lung cancer studies
– Prostate cancer investigations
– Ovarian cancer research
– Head and neck cancer treatment development
Research Benefits
– High cytotoxic activity against tumor cells
– Excellent stability in laboratory conditions
– Well-documented pharmacological profile
– Versatile application in various cancer types
– Established safety data for clinical translation
Quality Assurance
Each batch of BIORLAB’s docetaxel undergoes:
– Rigorous purity testing
– Identity confirmation
– Stability assessment
– Structural verification
– Bioactivity validation
Storage and Handling
– Store at -20°C
– Protect from light and moisture
– Stable for 2 years under recommended conditions
– Available in research-grade packaging
Research Support
BIORLAB provides comprehensive technical support including:
– Detailed analytical documentation
– Method development assistance
– Stability data
– Application Guidance
– Custom synthesis options
Please contact our technical support team for inquiries about bulk quantities or custom specifications.
*Note: For research use only. Not for human or veterinary diagnostic or therapeutic use.*